Atovaquone Oral Suspension 81033-0105

Generic: Atovaquone

Product NDC

81033-0105

Manufacturer: Kesin Pharma Corporation
Dosage Form: Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: February 6, 2026
Listing Expires: December 31, 2027
Application: ANDA210510

Need to source Atovaquone Oral Suspension? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Atovaquone	750 mg/5mL

Drug Class

Antimalarial [EPC]Antiprotozoal [EPC]Antimalarial [EPC]

Packaging Options(2)

81033-0105-22

20 CUP, UNIT-DOSE in 1 CARTON (81033-105-22) / 5 mL in 1 CUP, UNIT-DOSE (81033-105-05)

View →

81033-0105-42

42 CUP, UNIT-DOSE in 1 CARTON (81033-105-42) / 5 mL in 1 CUP, UNIT-DOSE (81033-105-05)

View →